fightaging.org /1 month ago

PD-L1 Blockade in the Brain Restores Measures of Glial Cell Function

PD-L1 found on the surface of cells is a well known immune checkpoint protein. When it binds to the receptor PD-1 found on the surface of T cells and B cells, it acts to suppress i...

Read source
bioengineer.org /4 days ago

Local IL-12 and Flt3L mRNA Nanoparticles Control Checkpoint-Resistant Melanoma in Mice

Intratumoral co-administration of IL-12 and Flt3L mRNA lipid nanoparticles controlled anti-PD-1-refractory melanoma in mouse models by coordinating dendritic, natural killer, and T...

Read source
bioengineer.org /1 month ago

Immune Cells Cluster Around Blood Vessels to Predict Lung Cancer Immunotherapy Success

Immunotherapy has transformed the treatment landscape for non-small cell lung cancer, the most common form of lung malignancy worldwide, yet a stubborn problem persists: only a sub...

Read source
scitechdaily.com /1 week ago

Cancer Immunotherapy Has a Dangerous Side Effect. Scientists May Have Found a Way To Stop It

Cancer immunotherapy could become safer by stabilizing the cells that keep immune responses under control, an approach that reversed treatment-related inflammation in mice. Some ca...

Read source
bioengineer.org /1 month ago

Staphylococcal Protein Reprograms Liver Tumor Macrophages to Boost Immunotherapy

One of the most stubborn obstacles in cancer immunotherapy is not the tumor cell itself but the cellular entourage that surrounds it. In hepatocellular carcinoma, the most common f...

Read source
edtimes.in /1 month ago

First-Line Immunotherapy for Cancer: How the Treatment Order Is Changing in India

Mumbai (Maharashtra) [India], October 12: For much of the past two decades, immunotherapy was thought of as a treatment held in reserve — an option to try after chemotherapy and ra...

Read source
timesofindia.indiatimes.com /4 weeks ago

Biosimilar drugs breaking high-cost barrier to cancer immunotherapy

Recent changes in cancer care in India show an increase in immunotherapy prescriptions due to affordable biosimilars. Doctors report that the availability of cheaper versions of ni...

Read source
bioengineer.org /1 month ago

Hidden armies inside glioblastoma: exhausted T cells hint at new immunotherapy routes

Single-cell analysis of 56 glioblastoma tumors reveals that T-cell-rich cases harbor clonally expanded, LAG3-high CD8 T cells that may be tumor-reactive, opening new avenues for im...

Read source
bioengineer.org /1 month ago

IDO1 Inhibitor Plus Melanoma Vaccine Fails to Boost Tumor-Fighting T Cells in Trial

A carefully designed clinical trial that set out to supercharge the immune system’s attack on advanced melanoma has delivered a sobering but scientifically valuable verdict. Resear...

Read source
bioengineer.org /1 week ago

Immunotherapy Combined With Chemotherapy Extends Survival in Advanced SMARCA4-Deficient Lung Cancer

A real-world retrospective study demonstrates that adding first-line immunotherapy to chemotherapy significantly prolongs median overall survival by 23 months in advanced SMARCA4-d...

Read source
newswire.com /1 week ago

Aptevo Presents Preclinical Data at SITC 2026 Showing Potential to Overcome Immune Suppression in Solid Tumors

In lab studies, APVO451 and APVO452 helped immune cells kill cancer cells despite conditions that suppress immune activity - offering potential for difficult-to-treat solid tumorsP...

Read source
genengnews.com /3 days ago

Targeting Folate Receptor Reverses Colorectal Cancer’s Resistance to Immunotherapy in Mice

Targeting FOLR1 with an approved antibody-drug conjugate restored anti-tumor immunity and enhanced anti-PD-1 effectiveness in colorectal cancer, overcoming immune evasion in mouse...

Read source
sciencedaily.com /2 weeks ago

MIT scientists turn immune cells into cancer killers inside the body

MIT scientists have developed nanoparticles that reprogram immune cells directly inside the body to attack cancer and harmful immune cells, eliminating tumors and reversing liver d...

Read source
bioengineer.org /2 hours ago

Anti-PD-1 Therapy Modulates HIV-Specific CD8+ T Cells in Men with HIV

A clinical trial of anti-PD-1 therapy in men with HIV and cancer demonstrates complex changes in HIV-specific CD8+ T-cell phenotypes and clonal distribution.

Read source
sciencedaily.com /1 month ago

Bowel cancer “melted away” after immunotherapy, then stayed away

A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patient...

Read source
sciencedaily.com /4 weeks ago

Scientists discover a hidden immune weapon against deadly lung cancer

Researchers have uncovered a hidden immune defense capable of attacking small cell lung cancer, an extremely aggressive disease that often escapes conventional treatments. The spec...

Read source
scitechdaily.com /1 month ago

Scientists Turn a Cancer-Fueling Protein Into a Powerful New Weapon Against Tumors

A protein that helps cancer grow could become an unlikely ally in treating it, with laboratory and mouse experiments showing that activating it in engineered immune cells curbs tum...

Read source
newatlas.com /1 month ago

An overlooked immune cell offers a way to treat deadliest lung cancers

An overlooked population of immune cells could offer a new way to attack one of the deadliest forms of lung cancer.Continue ReadingCatego...

Read source
qchron.com /2 weeks ago

Phase II Study of Ivonescimab in the Perioperative Setting for Resectable NSCLC Published in Nature Medicine

HONG KONG, Nov. 5, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that results from a Phase II clinical study evaluating its first-in-class PD-1/VEGF bispecific antibod...

Read source
medicalxpress.com /1 month ago

Making pediatric cancer more 'visible' boosts immunotherapy response

High-risk neuroblastoma is one of the most aggressive forms of solid tumors affecting children, originating in the nervous system. While a newer class of targeted immunotherapy dru...

Read source
bioengineer.org /1 month ago

How a Cellular Stress Switch Helps Tumours Hide From the Immune System

A new review reveals how the unfolded protein response, a cellular stress-signalling network, helps tumours evade immune detection and could be targeted to boost cancer immunothera...

Read source
bioengineer.org /4 days ago

RNA Modification Regulates Melanoma Progression and Immune Response in Preclinical Studies

A comprehensive scientific review synthesizes preclinical evidence revealing how m6A RNA modification governs melanoma progression, immune escape, and response to checkpoint immuno...

Read source
scitechdaily.com /2 weeks ago

A Hidden Cancer-Fighting Switch Could Supercharge the Human Immune System

Temporarily activating a protein best known for preventing cancer helped engineered human immune cells kill melanoma cells more effectively in the lab, suggesting a way to improve...

Read source
genengnews.com /1 week ago

Therapeutic Immune Manipulation

Next-generation immunotherapy exploits diverse immune populations to address the challenges that CAR T-cell therapy faces. The post Therapeutic Immune Manipulation appeared first o...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.